WHO Media
| Friday, 12 November 2021 POST PRESSER LINKS COVID-19 Virtual Press Conference Please find below links from the COVID-19 virtual press conference held earlier today. Highlights from WHO Director-General's opening remarks: - Almost 2 million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic started.
- Every day, there are six times more boosters administered globally than primary doses in low-income countries. To reach WHO’s target of vaccinating 40% of the population of every country by the end of this year, we need an additional 550 million doses – about 10 days’ production. Vaccines alone will not end the pandemic, but we cannot end the pandemic unless we solve the global vaccine crisis.
- COVID-19 is not the only vaccine crisis we face. A new report by WHO and the US Centers for Disease Control and Prevention shows that more than 22 million infants missed their first dose of measles vaccine last year – 3 million more than in 2019, marking the largest increase in two decades.
- This Sunday is World Diabetes Day, and this year we are celebrating the 100th anniversary of insulin. One in every two people who need insulin for type 2 diabetes does not get it. A new WHO report finds that high prices, low availability of human insulin, a market dominated by 3 companies, and weak health systems are the main barriers to universal access.
Audio file (55mins):
https://who.canto.global/b/N8ED7 Weblink:
https://terrance.who.int/mediacentre/presser/WHO-AUDIO_Emergencies_Coronavirus_Press_Conference_12NOV2021.mp3 Video news package (4mins39):
https://who.canto.global/b/S45DN RELATED: New WHO report maps barriers to insulin availability and suggests actions to promote universal access
Global progress against measles threatened amidst COVID-19 pandemic  You are receiving this NO-REPLY email because you are included on a WHO mail list.
If you have been forwarded this update you can click here to subscribe.
Journalists may send feedback to WHO Media Team |
No comments:
Post a Comment